York Capital Management Global Advisors, LLC Hutchmed (China) LTD Transaction History

York Capital Management Global Advisors, LLC

$81.4 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$28.89 - $35.33 $12.1 Million - $14.8 Million	-419,169 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $8.45 Million - $10.2 Million	236,872 Added 129.94%	419,169 $15.3 Million
Q2 2021 Aug 16, 2021	BUY	$23.7 - $39.27 $4.32 Million - $7.16 Million	182,297 New	182,297 $7.16 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

6.88M

Call Options Held

6.2K

Put Options Held

1.1K

Schroder Investment Management Group London, X0

2.92M
Shares

$43.4 Million
0.06% of portfolio
Allianz Asset Management Gmb H Munich, 2M

1.32M
Shares

$19.7 Million
0.04% of portfolio
State Street Corp Boston, MA

350K
Shares

$5.19 Million
0.0% of portfolio
Aia Group LTD Hong Kong, K3

315K
Shares

$4.69 Million
0.17% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

310K
Shares

$4.61 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.57B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of York Capital Management Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Capital Management Global Advisors, LLC with notifications on news.

Account